Inflammation|OMICS International|Clinical Trials

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


Inflammation is a response to altered homeostasis and occur by releasing different cytokines e.g. tumor necrosis factor α, interleukin-1,4,6,10 from the endocrine. Inflammatory markers, such as cytokines are correlated with increase in mortality and morbidity in patients with cardiac disease, and are associated with a reduction in HRV mainly SDNN, VLF power and LF power in patients with coronary artery disease, or with heart failure. Inflammation increases both sympathetic and parasympathetic activities but also the oxidative stress.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021